Leadless Cardiac Pacemaker with Secondary Fixation Capability

• US 20090082828A1
• Filed: 09/19/2008
• Published: 03/26/2009
• Est. Priority Date: 09/20/2007
• Status: Abandoned Application

• Current Assignee: Nanostim, Inc (Abbott Laboratories)
• Original Assignee: Nanostim, Inc (Abbott Laboratories)
• Inventors: Ostroff, Alan
• Application Number:
  US12/234,226
• Publication Number:
  US 20090082828A1
• Time in Patent Office: Days
• US Class Current: 607/36
• CPC Class Codes: A61N 1/0573 chacterised by means penetrating the heart tissue, e.g. helix needle or hook
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/37516 Intravascular implants
• CPC Class Codes: A61N 1/37518 Anchoring of the implants, e.g. fixation
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators

Abstract

The invention relates to leadless cardiac pacemakers (LBS), and elements and methods by which they affix to the heart. The invention relates particularly to a secondary fixation of leadless pacemakers which also include a primary fixation. Secondary fixation elements for LBS'"'"'s may either actively engage an attachment site, or more passively engage structures within a heart chamber. Active secondary fixation elements include a tether extending from the LBS to an anchor at another site. Such sites may be either intracardial or extracardial, as on a vein through which the LBS was conveyed to the heart, the internal or external surface thereof. Passive secondary fixation elements entangle within intraventricular structure such as trabeculae carneae, thereby contributing to fixation of the LBS at the implant site.

Claims

1. A leadless biostimulator comprising:

a power source adapted to be disposed within a human heart chamber;

an electrode in electrical communication with the power source and adapted to be placed in contact with tissue within the heart chamber;

a controller adapted to be disposed within the heart chamber and to control delivery of electrical energy from the power source to the electrode;

a primary fixation element adapted to affix the biostimulator to a primary fixation site on a heart wall within the heart chamber; and

a downstream vascular escape prevention assembly adapted to prevent an escape of the biostimulator in the event of it being dislodged from the primary fixation site.

2. The leadless biostimulator of claim 1 further comprising a housing in which the power source, the electrode, and the controller are disposed.

3. The leadless biostimulator of claim 1 wherein the heart chamber into which the biostimulator is adapted to be implanted is any of the right ventricle, left ventricle, right atrium, or left atrium.

4. The leadless biostimulator of claim 1 wherein the downstream vascular escape prevention assembly comprises one or more entangling elements adapted to entangle within heart structure at one or more secondary fixation sites within the chamber of the heart.

5. The leadless biostimulator of claim 4 wherein the one or more entangling elements comprise any of tines, hooks, or chains.

6. The leadless biostimulator of claim 4 wherein the entangling elements are adapted to extend radially outward beyond the diameter of the biostimulator when implanted within the heart chamber.

7. The leadless biostimulator of claim 4 wherein the entangling elements are at least 5 mm in length.

8. The leadless biostimulator of claim 4 wherein the entangling elements extend outward from the biostimulator at a proximal-facing angle that ranges from about 10 degrees to about 90 degrees from the axis of the biostimulator.

9. The leadless biostimulator of claim 4 wherein the tines are configured as any of straight tines, curvilinear tines, or convoluted tines.

10. The leadless biostimulator of claim 4 wherein the entangling elements are adapted to be rotatable with respect to the biostimulator.

11. The leadless biostimulator of claim 10 wherein the entangling elements are mounted on a rotatable collar encircling the main axis of the biostimulator.

12. The leadless biostimulator of claim 4 wherein the entangling elements are configured such that they are distally collapsible around the periphery of the biostimulator.

13. The leadless biostimulator of claim 12 wherein the collapsible entangling elements, when collapsed, are configured to be substantially contained within a maximal diameter of the biostimulator.

14. The leadless biostimulator of claim 1 wherein the downstream vascular escape prevention assembly comprises a tether and an anchor adapted to anchor at a secondary attachment site, the tether connecting the assembly and the anchor to each other.

15. The leadless biostimulator of claim 14 wherein the anchor includes comprises a screw, a hook, a clip, a stent, a cage, and/or a barb adapted to attach the biostimulator to the secondary attachment site.

16. The leadless biostimulator of claim 14 wherein the secondary attachment site may be any of an intracardiac site, an intravascular site, or an extravascular site.

17. The leadless biostimulator of claim 16 wherein the intracardiac site is a septal wall of the heart.

18. The leadless biostimulator of claim 16 wherein the intravascular site is located within a vessel through which the biostimulator is adapted to be delivered to the heart.

19. The leadless biostimulator of claim 18 wherein the vessel includes any of the femoral vein or the inferior vena cava.

20. The leadless biostimulator of claim 18 wherein the tether is formed from two segments secured together with a clip.

21. The leadless biostimulator of claim 16 wherein the extravascular site includes the external periphery of a vessel through which the biostimulator was delivered to the heart.

22. The leadless biostimulator of claim 21 wherein the tether is adapted to be threaded through the vessel wall and is attached to the anchor, the anchor comprising any of a partial cylinder, a plate, and/or a ball.

23. The leadless biostimulator of claim 14 wherein the anchor comprises one or more electrodes for biostimulation, and wherein the tether is electrically conductive.

24. The leadless biostimulator of claim 14 wherein the tether comprises any of single strand wire, multistranded wire, monofilament suture thread, or multistrand suture thread.

25. The leadless biostimulator of claim 14 wherein the tether comprises a biodegradable material.

26. The leadless biostimulator of claim 14 wherein the tether comprises an antithrombogenic agent.

27. The leadless biostimulator of claim 1 further comprising one or more soluble coverings configured to encapsulate any of the primary fixation element or the secondary fixation element.

28. The leadless biostimulator of claim 27 wherein the soluble covering is biocompatible.

29. The leadless biostimulator of claim 27 wherein the soluble covering comprises any of a polymer, a protective sugar, or a protective salt.

30. The leadless biostimulator of claim 29 wherein the protective sugar is mannitol.

31. The leadless biostimulator of claim 29 wherein the polymer is polyvinylpyrrolidone.

32. The leadless biostimulator of claim 27 wherein the secondary element is collapsible around the periphery of the biostimulator, and wherein the soluble covering secures the secondary element in a collapsed configuration.

33. A method for retaining a leadless intracardiac biostimulator in a heart in the event of dislodgement from a primary fixation site comprising:

entangling an element of the biostimulator within the heart structure at a secondary fixation site within a heart chamber, such entanglement being sufficient to retain the biostimulator within the cardiac chamber.

34. The method of claim 33 wherein entangling an element of the biostimulator within a heart structure comprises entangling the element within a structure in the left ventricle.

35. The method of claim 33 wherein entangling an element of the biostimulator within a heart structure comprises entangling the element within a structure in the right ventricle.

36. The method of claim 33 further including preventing escape of the biostimulator into a downstream vascular site.

37. The method of claim 36 wherein preventing escape of the biostimulator into a downstream vascular site comprises preventing escape into the pulmonary artery.

38. The method of claim 36 wherein preventing escape of the biostimulator into a downstream vascular site comprises preventing escape into the aorta.

39. A method for retaining a leadless intracardiac biostimulator in a heart in the event of dislodgement from a primary fixation site comprising:

anchoring the biostimulator with a tether to a secondary fixation site, the tether being of appropriate length to prevent substantial movement of the biostimulator into a downstream vascular from the primary fixation site of the biostimulator in a heart chamber.

40. The method of claim 39 wherein anchoring the biostimulator with a tether comprises anchoring the biostimulator with a tether of appropriate length to retain the biostimulator within the heart chamber.

41. The method of claim 39 wherein anchoring the biostimulator with a tether comprises attaching the tether to an anchor at the secondary fixation site.

42. The method of claim 41 wherein anchoring comprises attaching the tether to the secondary fixation site with any of a screw, a hook, a clip, a stent, a cage, or a barb.

43. The method of claim 39 wherein anchoring the biostimulator to a secondary fixation site comprises anchoring to any of an intracardiac site or an extracardial site.

44. The method of claim 43 wherein anchoring to an extracardial site comprises anchoring to a site on a vessel through which the biostimulator was delivered to the heart.

45. The method of claim 44 wherein the anchoring to a site on a vessel through which the biostimulator was delivered to the heart comprises anchoring to a site on any of the internal or exterior surface of the vessel.

46. The method of claim 39 wherein anchoring with a tether comprises combining two tethers to form a single tether, the method comprising:

inserting the biostimulator attached to a first tether into an entry site in the vasculature, advancing the biostimulator to an intracardial implant site, and implanting the biostimulator at that site;

inserting a secondary anchor attached to a second tether into the entry site in the vasculature, advancing the anchor to the secondary fixation site, and implanting the anchor at that site; and

engaging the tether of the biostimulator and the tether of the anchor within a slidable clip at the vascular entry site to form a combined tether.

47. The method of claim 46 further comprising:

adjusting the length of the combined tether by slidably advancing the clip within the vasculature toward the secondary fixation site; and

securing the first tether and the second tether at the clip so that no further sliding can occur.

48. The method of claim 47further comprising removing remnant lengths of the first tether and second tether that extend from the clip through the vasculature entry site.

49. The method of claim 47 wherein adjusting the length of the tether includes removing slack in the tether.